University of California San Francisco

Publications

  1. ASO Visual Abstract: Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    2025 | PubMed
  2. ASO Visual Abstract: Essential Elements in Synoptic Operative Reports for Hepato-Pancreato-Biliary Cancer Surgery-An HPB/CGSO Training Program Survey.
    2024 | PubMed
  3. Essential Elements in Synoptic Operative Reports for Hepato-Pancreato-Biliary Cancer Surgery: An HPB/CGSO Training Program Survey.
    2024 | PubMed
  4. Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC).
    2024 | PubMed
  5. Graft choice in pancreatectomy with vascular resection: equivalent safety in selected patients.
    2024 | PubMed
  6. ASO Author Reflections: Is Adjuvant Therapy Necessary for All Patients with Invasive Mucinous Cystic Neoplasms of the Pancreas? Let's De-escalate.
    2024 | PubMed
  7. ASO Visual Abstract: Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
    2024 | PubMed
  8. Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    2024 | PubMed
  9. Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct expression patterns and potential markers of progression.
    2024 | PubMed
  10. The impact of the California state lockdown during the COVID-19 pandemic on management of patients with pancreatic ductal adenocarcinoma.
    2024 | PubMed
  11. Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.
    2024 | PubMed
  12. Insights on liver-directed surgical innovations, targeted therapies, and immunotherapy for biliary tract cancer: navigating the new European Society for Medical Oncology (ESMO) Clinical Practice Guidelines.
    2024 | PubMed
  13. Pancreas Cyst Diagnosis and Advances in Cyst Fluid Analysis.
    2024 | PubMed
  14. Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors.
    2024 | PubMed
  15. Intraoperative hepatic artery infusion pump perfusion testing with indocyanine green near-infrared imaging offers multiple potential advantages.
    2024 | PubMed
  16. "Mickey Mouse sign" to identify and remove cystic duct stones in postcholecystectomy syndrome.
    2024 | PubMed
  17. Improved survival of patients receiving immunotherapy and chemotherapy following curative-intent resection of colorectal liver metastases.
    2024 | PubMed
  18. Educating Cancer-Associated Fibroblasts (CAFs): Are They the Student or the Teacher?
    2024 | PubMed
  19. Surgical Cancer Care in Safety-Net Hospitals: a Systematic Review.
    2023 | PubMed
  20. Impact of safety-net hospital burden on achievement of textbook oncologic outcomes following resection in for stage I-IV colorectal cancer.
    2023 | PubMed
  21. A Machine Learning Approach to Predict Postoperative Pancreatic Fistula After Pancreaticoduodenectomy Using Only Preoperatively Known Data.
    2023 | PubMed
  22. ASO Visual Abstract: National Practice Patterns in Malignant Peritoneal Mesothelioma-Updates in Management and Survival.
    2023 | PubMed
  23. Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune Tolerance.
    2023 | PubMed
  24. National Practice Patterns in Malignant Peritoneal Mesothelioma: Updates in Management and Survival.
    2023 | PubMed
  25. It is not necessary to resect all mucinous cystic neoplasms of the pancreas: current guidelines do not reflect the actual risk of malignancy.
    2023 | PubMed
  26. Drain Placement After Pancreatic Resection: Friend or Foe For Surgical Site Infections?
    2023 | PubMed
  27. Hypertension Requiring Medication Use: a Silent Predictor of Poor Outcomes After Pancreaticoduodenectomy.
    2023 | PubMed
  28. The Landmark Series: Intraductal Papillary Mucinous Neoplasms of the Pancreas-From Prevalence to Early Cancer Detection.
    2023 | PubMed
  29. Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States.
    2022 | PubMed
  30. Hand-Assisted Versus Pure Minimally-Invasive Distal Pancreatectomy: Is There a Downside to Lending a Hand?
    2022 | PubMed
  31. Minimally Invasive Distal Pancreatectomy Techniques: A Contemporary Analysis Exploring Trends, Similarities, and Differences to Open Surgery.
    2022 | PubMed
  32. The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms.
    2022 | PubMed
  33. Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysis.
    2022 | PubMed
  34. Physical exam reveals etiology of liver and pancreatic tumors.
    2022 | PubMed
  35. Langer's arch: An anatomic variant complicating axillary node dissection.
    2022 | PubMed
  36. Robotic Surgery for Biliary Tract Cancer.
    2022 | PubMed
  37. LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer.
    2022 | PubMed
  38. Clinical Presentation Patterns and Survival Outcomes of Hispanic Patients With Gastric Cancer.
    2021 | PubMed
  39. Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety-Net Collaborative analysis.
    2021 | PubMed
  40. The Evolution of Cancer Immunotherapy.
    2021 | PubMed
  41. Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers?
    2021 | PubMed
  42. Race and Gender Differences in Awareness of Colorectal Cancer Screening Tests and Guidelines Among Recently Diagnosed Colon Cancer Patients in an Urban Setting.
    2021 | PubMed
  43. Combining On-Table Embolization with Immediate Resection to Safely Excise Giant Hepatic Hemangiomas.
    2021 | PubMed
  44. Combination Immunotherapy With LIGHT and Interleukin-2 Increases CD8 Central Memory T-Cells In Vivo.
    2021 | PubMed
  45. ASO Author Reflections: How Can We Improve the Postoperative Experience for Our Pancreatic Cancer Patients? A Practical Technique to Optimize Pain Control After Major Abdominal Surgery.
    2020 | PubMed
  46. Surgeon-Placed Continuous Wound Infusion Pain Catheters Markedly Decrease Narcotic Use and Improve Outcomes After Pancreatic Tumor Resection.
    2020 | PubMed
  47. Epidural Analgesia Is Associated with Prolonged Length of Stay After Open HPB Surgery in Over 27,000 Patients.
    2020 | PubMed
  48. Perioperative Broad-spectrum Antibiotics are Associated With Decreased Surgical Site Infections Compared to 1st-3rd Generation Cephalosporins After Open Pancreaticoduodenectomy in Patients With Jaundice or a Biliary Stent.
    2020 | PubMed
  49. Should Drains Suck? A Propensity Score Analysis of Closed-Suction Versus Closed-Gravity Drainage After Pancreatectomy.
    2020 | PubMed
  50. Oncolytic adenovirus encoding LIGHT (TNFSF14) inhibits tumor growth via activating anti-tumor immune responses in 4T1 mouse mammary tumor model in immune competent syngeneic mice.
    2020 | PubMed
  51. Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations.
    2020 | PubMed
  52. A propensity score analysis of over 12,000 pancreaticojejunal anastomoses after pancreaticoduodenectomy: does technique impact the clinically relevant fistula rate?
    2020 | PubMed
  53. MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer.
    2019 | PubMed
  54. Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential.
    2019 | PubMed
  55. Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer.
    2019 | PubMed
  56. Impact of Immunotherapy after Resection of Pancreatic Cancer.
    2019 | PubMed
  57. Molecular aberrations and signaling cascades implicated in the pathogenesis of anaplastic thyroid cancer.
    2018 | PubMed
  58. Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association.
    2018 | PubMed
  59. Does attending a Delphi consensus conference impact surgeon attitudes? Survey results from the Americas HepatoPancreatoBiliary Association consensus conference on small asymptomatic pancreatic neuroendocrine tumors.
    2018 | PubMed
  60. Therapeutic advances in anaplastic thyroid cancer: a current perspective.
    2018 | PubMed
  61. ASO Author Reflections: Improving Identification of Intraductal Papillary Mucinous Neoplasm Patients at Risk-Current Status and the Role of IPMN Molecular Biomarkers.
    2018 | PubMed
  62. Identification of a Novel OX40L+ Dendritic Cell Subset That Selectively Expands Regulatory T cells.
    2018 | PubMed
  63. KRASG12D and TP53R167H Cooperate to Induce Pancreatic Ductal Adenocarcinoma in Sus scrofa Pigs.
    2018 | PubMed
  64. Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases.
    2018 | PubMed
  65. Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation.
    2018 | PubMed
  66. What is the Incidence of Malignancy in Resected Intraductal Papillary Mucinous Neoplasms? An Analysis of Over 100 US Institutions in a Single Year.
    2018 | PubMed
  67. Do Drains Contribute to Pancreatic Fistulae? Analysis of over 5000 Pancreatectomy Patients.
    2018 | PubMed
  68. Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas.
    2017 | PubMed
  69. Port-Site Resection in the Surgical Management of Incidental Gallbladder Cancer: A Still Inconclusive Question: A Reply.
    2017 | PubMed
  70. Examining racial disparities in colon cancer clinical delay in the Colon Cancer Patterns of Care in Chicago study.
    2017 | PubMed
  71. The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform.
    2017 | PubMed
  72. PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells.
    2017 | PubMed
  73. Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia.
    2017 | PubMed
  74. A Technique to Define Extrahepatic Biliary Anatomy Using Robotic Near-Infrared Fluorescent Cholangiography.
    2017 | PubMed
  75. Targeting cancer with tumor-specific therapeutic strategies-metabolic reprogramming beyond the Warburg effect.
    2017 | PubMed
  76. Mitochondrial protein 18 (MTP18) plays a pro-apoptotic role in chemotherapy-induced gastric cancer cell apoptosis.
    2017 | PubMed
  77. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    2017 | PubMed
  78. LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases.
    2017 | PubMed
  79. Isolated Pancreatic Uncinate Duct IPMN.
    2017 | PubMed
  80. Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death.
    2017 | PubMed
  81. Can Colon Cancer Recurrence and Metastases Be Determined After Surgical Resection Using a Gene Expression Signature?
    2017 | PubMed
  82. Gene-expression profiling to predict responsiveness to immunotherapy.
    2016 | PubMed
  83. Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosis.
    2016 | PubMed
  84. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
    2016 | PubMed
  85. Techniques to perform robotic left adrenalectomy in the obese patient.
    2016 | PubMed
  86. Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis.
    2016 | PubMed
  87. A Minimally Invasive Technique to Obtain Optimal Tumor Margins in Anatomically Confined Locations Using a Contoured Stapler.
    2015 | PubMed
  88. Precise identification of immunotherapeutic targets for solid malignancies using clues within the tumor microenvironment-Evidence to turn on the LIGHT.
    2015 | PubMed
  89. The Potential of Intralesional Rose Bengal to Stimulate T-Cell Mediated Anti-Tumor Responses.
    2015 | PubMed
  90. Techniques to perform a laparoscopic right adrenalectomy for metastases abutting the liver, renal vein, and posterior vena cava.
    2015 | PubMed
  91. Symptomatic Massive Splenomegaly in Persistent Polyclonal B-cell Lymphocytosis Requiring Splenectomy.
    2015 | PubMed
  92. Tailoring GIST therapy—biology is still king.
    2015 | PubMed
  93. Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features.
    2015 | PubMed
  94. Simultaneous Occurrence of Glandular and Neuroendocrine Components in Lymph Node Metastasis of Gastric MANEC.
    2015 | PubMed
  95. Closure of Melanoma Defects on the Sole of the Foot Using Glaborous Skin: The End of the Flap?
    2015 | PubMed
  96. Operative management of portal annular pancreas during pancreaticoduodenectomy.
    2015 | PubMed
  97. Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases.
    2015 | PubMed
  98. Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms.
    2014 | PubMed
  99. Appendicitis secondary to metastatic melanoma: review of the National Institutes of Health experience.
    2014 | PubMed
  100. Calcifying fibrous tumor of the small intestine associated with Castleman-like lymphadenopathy.
    2014 | PubMed
  101. Dedifferentiated gastrointestinal stromal tumor arising de novo from the small intestine.
    2014 | PubMed
  102. IG20/MADD plays a critical role in glucose-induced insulin secretion.
    2013 | PubMed
  103. Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer.
    2013 | PubMed
  104. Benign adrenal hemangiomas may mimic metastases on PET.
    2013 | PubMed
  105. Management of patients with abdominal malignancy after remote jejunoileal bypass: surgical considerations decades later.
    2013 | PubMed
  106. A technique for laparoendoscopic resection of posterior fundic gastric GISTs without need for a gastrotomy.
    2013 | PubMed
  107. Survival after resection of cutaneous adnexal carcinomas with eccrine differentiation: risk factors and trends in outcomes.
    2013 | PubMed
  108. Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases.
    2013 | PubMed
  109. MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells.
    2013 | PubMed
  110. Primary hepatic lymphoma presenting as an isolated solitary hepatic cyst.
    2012 | PubMed
  111. Can we predict which residents are going to pass/fail the oral boards?
    2012 | PubMed
  112. Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.
    2012 | PubMed
  113. Malignant masquerade of xanthogranulomatous cholecystitis on intraoperative ultrasound of the liver.
    2012 | PubMed
  114. Video: totally laparoscopic left lateral segmentectomy for hepatic malignancies: a modified technique.
    2011 | PubMed
  115. Is port site resection necessary in the surgical management of gallbladder cancer?
    2011 | PubMed
  116. Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells.
    2011 | PubMed
  117. Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas.
    2011 | PubMed
  118. Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.
    2010 | PubMed
  119. Randomized clinical trials in pancreatic adenocarcinoma.
    2010 | PubMed
  120. Novel presentation of a familial pancreatic cancer syndrome.
    2008 | PubMed
  121. Cytology from pancreatic cysts has marginal utility in surgical decision-making.
    2008 | PubMed
  122. Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma.
    2006 | PubMed
  123. Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2.
    2006 | PubMed
  124. Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade.
    2005 | PubMed
  125. Images in cardiothoracic surgery. Active malignant pleural effusion captured through the thoracoscope.
    2005 | PubMed
  126. Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma.
    2005 | PubMed
  127. Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study.
    2005 | PubMed
  128. Loss of S100 antigenicity in metastatic melanoma.
    2005 | PubMed
  129. Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.
    2005 | PubMed
  130. Rapid acute amiodarone-induced hepatotoxicity in a burn patient.
    2005 | PubMed
  131. Insulin receptor (IR) and glucose transporter 2 (GLUT2) proteins form a complex on the rat hepatocyte membrane.
    2005 | PubMed